Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Remote case management to prevent suicide after psychiatric hospital discharge

Official title: SAFEGUARD Phase 2 Pathfinding Study

Run by Uniformed Services University of the Health Sciences · NCT07404787 · Data updated 2026-11-12

This project will test whether a 6-month remote program called Pathfinding helps active-duty Army soldiers reduce suicidal behavior after leaving inpatient psychiatric care.

More Suicide trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1500 (estimated)
SponsorUniformed Services University of the Health Sciences
Federal
Locations1 site (Bethesda, Maryland)
StatusRecruiting
StartedFebruary 24, 2026
Main results expectedAugust 31, 2028
Study endsAugust 31, 2029
Registry record updatedSeptember 11, 2026
Trial IDNCT07404787 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Active-duty Regular Army soldiers recently discharged from inpatient psychiatric care at a U.S. military treatment facility who can use a telephone or computer and can provide informed consent are the intended participants.

Probably not a fit

Those with impaired ability to consent, a terminal illness, a positive screen for post-discharge suicide-related behaviors, or who cannot complete the baseline survey within 30 days of discharge are excluded and unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Active-duty Regular Army soldiers discharged from inpatient psychiatric care at military treatment facilities across the U.S. will be identified and invited to participate. Consenting participants will be randomized to receive usual post-discharge care (TAU) or TAU plus Pathfinding, a six-month telehealth case management intervention delivered by centrally trained masters-level mental health professionals. Participants complete a baseline assessment and follow-up assessments at 6 and 12 months, with additional review of electronic health records and Army administrative data. The intervention adapts elements of CLASP and CTI for a military population to provide scalable, remote support during the high-risk post-discharge period.

Why it matters

Potential benefit: If successful, Pathfinding could reduce post-discharge suicidal behaviors and improve continuity of care for soldiers returning to the community.

How similar studies have gone: Elements from CLASP and CTI have previously reduced post-discharge suicidal behavior, but combining them into a remotely delivered program for active-duty soldiers is a novel adaptation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Active duty Regular Army soldiers recently discharged from inpatient psychiatric care at a military treatment facility in the US
* Access to telephone and computer (including smartphone)

Exclusion Criteria:

* Impaired ability to provide informed consent
* Terminal illness
* Failure to complete baseline survey within 30 days of discharge
* Positive screen for post-discharge suicide-related behaviors

Where it's running

  • Uniformed Services University of the Health Sciences
    Bethesda, Maryland, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.